Skip to contentR
Rigel Pharmaceuticals Inc
R
RIGLRigel Pharmaceuticals Inc Released Nov 3, 2015, after the close
10-Q filed Nov 3, 2015, 34 days after period end · 0001558370-15-002179
Q3 2015 · 10-Q
Revenue—
Net income—
EPS Diluted-$0.08-$0.08N/M vs Q3 2014 No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
N/M vs Q2 2015
Operating Income-$6,781,000N/M Operating Cash Flowderived-$9,457,000N/M Free Cash Flowderived-$9,764,000N/M ended Sep 30, 2015 · filed Nov 3, 2015 · 34 d after period end
+8.9% from the close of Nov 2, 2015 to the close of Nov 4, 2015, the first after the release.
after the close$2.81$3.06 Oct 1Nov 3Dec 7